Stem Cell Therapy for Diabetic Foot Ulcers: Theory and Practice

Area of Science:

• Regenerative Medicine
• Diabetology
• Wound Healing

Background:

• Diabetic foot ulcers (DFUs) are a major cause of morbidity, mortality, and limb amputation.
• Current treatments for DFUs have limitations, necessitating novel therapeutic approaches.
• Stem cell therapy is emerging as a potential adjuvant treatment for DFUs.

Purpose of the Study:

• To review the current literature on the application, safety, and efficacy of stem cell therapy for diabetic foot ulcers.
• To evaluate the success rates and potential benefits of stem cell application in preventing amputations.

Main Methods:

• A comprehensive literature review was conducted using major scientific databases (PubMed, Scopus, Web of Science).
• Included studies comprised randomized controlled trials and article journals focusing on stem cell therapy for DFUs.
• Five credible cohorts involving 216 participants (151 males, 65 females; mean age 64.5 ± 9.6 years) were analyzed.

Main Results:

• Stem cell application demonstrated an average success rate of 86.41% in treating Wagner-II diabetic foot ulcers.
• Mesenchymal stem cells were found to be safe and effective in the analyzed cohorts.
• The therapy showed significant potential in preventing limb amputations associated with DFUs.

Conclusions:

• Stem cell application is a safe and effective adjuvant therapy for diabetic foot ulcers.
• This regenerative medicine approach can significantly reduce the incidence of limb amputations in diabetic patients.
• Further research into stem cell therapy holds promise for improving DFU management and patient outcomes.